Bag5 - BCL2-associated athanogene 5 Gene
Also Known as Bag-5; 1600025G07Rik; 4930405J06Rik
Species: Mus musculus
Summary
Predicted to enable adenyl-nucleotide exchange factor activity; chaperone binding activity; and enzyme binding activity. Predicted to be involved in several processes, including negative regulation of cellular protein metabolic process; negative regulation of protein refolding; and protein stabilization. Predicted to be located in inclusion body; mitochondrion; and perinuclear region of cytoplasm. Predicted to be active in cytosol; membrane; and nucleus. Orthologous to human BAG5 (BAG cochaperone 5). [provided by Alliance of Genome Resources, Apr 2022]
Bag5 Products (4)
| mRNA | Protein | Name |
|---|---|---|
| NM_001324480.1 | NP_001311409.1 | BAG family molecular chaperone regulator 5 |
| NM_001324481.1 | NP_001311410.1 | BAG family molecular chaperone regulator 5 |
| NM_001324482.1 | NP_001311411.1 | BAG family molecular chaperone regulator 5 |
| NM_027404.2 | NP_081680.1 | BAG family molecular chaperone regulator 5 |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
24510904 | MGI |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| part of junctional membrane complex |
IDA
IDA: Inferred from direct assay
|
35044787 | MGI |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
BAG family molecular chaperone regulator 5 |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS01346 | BAG5 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS22109 | Bag5 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS28631 | Bag5 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service